ArticleOncotarget2016

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

Evert van den Broek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.